Retraction: ECT2 Increases the Stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer (Front. Oncol., (2021), 10, 10.3389/fonc.2020.589241)

Abstract

The Journal and Authors retract the 8 February 2021 article cited above for the following reasons provided by the Authors: Following pub investigation, which was conducted in accordance with Frontiers’ policies. This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.